Low Hemoglobin in Multiple Myeloma: What It Means and When to Worry

Low hemoglobin (anemia) is very common in multiple myeloma and usually happens because myeloma cells in the bone marrow crowd out normal red blood cell production. This can lead to fatigue, shortness of breath, dizziness, and reduced exercise tolerance, and it often improves when the myeloma is treated or when supportive therapies are used. ^{[1] [2]}

---

Why Hemoglobin Drops in Multiple Myeloma

• Bone marrow crowding: Myeloma cells multiply in the marrow and reduce the production of healthy blood cells, causing anemia. ^{[1] [3]}
• Kidney involvement: Myeloma can impair kidney function, which reduces erythropoietin (a hormone that stimulates red blood cell production), contributing to anemia. ^{[2] [4]}
• Treatment effects: Certain therapies may also suppress bone marrow temporarily, adding to anemia risk. ^[4]

---

How Serious Is It?

Anemia in myeloma ranges from mild to severe; its impact depends on how low the hemoglobin is and whether you have symptoms like chest pain, shortness of breath at rest, palpitations, or lightheadedness. ^[5]
Many people with cancer experience anemia at some point, and it can often be managed safely with a combination of treating the myeloma and supportive care. ^{[6] [7]}
If hemoglobin falls to levels that are very low (often around the single digits in g/dL), your care team may consider interventions such as iron therapy, erythropoiesis-stimulating agents, or transfusion, depending on cause and symptoms. ^{[4] [5]}

---

Common Symptoms to Watch

• Fatigue and weakness that’s out of proportion to your usual energy. ^[5]
• Shortness of breath, especially with minimal exertion. ^[5]
• Dizziness, headaches, or feeling “foggy,” which can also be worsened by other myeloma-related factors. ^{[8] [9]}

Seek urgent evaluation if you have chest pain, fainting, severe shortness of breath, or rapid heartbeat along with low hemoglobin. ^[5]

---

What Your Doctor May Check

• Full blood count: Confirms hemoglobin level and looks at red cell indices. ^[10]
• Iron studies: To see if iron deficiency is contributing; iron support can help even when ferritin looks “okay” if iron isn’t bioavailable. ^[11]
• Kidney function and electrolytes: To assess myeloma-related kidney effects that worsen anemia. ^[2]
• Myeloma activity markers: Protein levels and marrow status to gauge disease control, since controlling the myeloma often improves anemia. ^[10]

---

Treatment Options

• Treat the myeloma: Reducing the number of myeloma cells in the marrow generally allows healthier blood cell production to recover. ^[1]
• Supportive therapies: Depending on cause, clinicians may use iron supplementation, erythropoiesis-stimulating agents, and red blood cell transfusions to relieve symptoms and improve oxygen delivery. ^{[4] [11]}
• Manage kidney health: Protecting and supporting kidney function can help improve anemia over time. ^[2]

---

When to Be Concerned

You should be particularly attentive if you notice rapidly worsening fatigue, breathlessness at rest, chest discomfort, or lightheadedness, or if your hemoglobin drops significantly from your baseline; these situations warrant timely medical review to decide on supportive therapy and assess myeloma control. ^[5]
Because anemia can reflect both disease activity and treatment effects, ongoing communication with your oncology team and regular labs are important to stay ahead of complications. ^{[10] [4]}

---

Key Takeaways

• Anemia is a common and expected complication of multiple myeloma due to bone marrow crowding and, at times, kidney involvement. It is usually manageable and often improves with effective myeloma treatment plus supportive care. ^{[1] [2]}
• Report symptoms promptly and follow your monitoring plan so your team can address both the cause and the symptoms of low hemoglobin early. ^{[5] [4]}